ArticleFuture oncology (London, England)2025

Paclitaxel-based strategy as first-line therapy for advanced breast cancer: a model-based economic evaluation for China.

Ji-Sheng Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.